Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions
Authors:
- 16 November 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 22 (1) , 117-129
Abstract
Introduction: The primary hyperoxalurias (PH) are rare, but underdiagnosed disorders where the loss of enzymatic activity in key compounds of glyoxylate metabolism results in excessive endogenous oxalate generation. Clinically, they are characterized by recurrent urolithiasis and/or nephrocalcinosis. PH type I is the most frequent and most devastating subtype often leading to early end-stage renal failure. Areas covered: Profound overview of clinical, diagnostic, and currently available treatment options with a focus on PH I at different stages of the disease. Discussion of future therapeutic avenues including pharmacological chaperones (small molecules rescuing protein function), gene therapy with safer adenoviral vectors, and potential application of cell-based transplantation strategies is provided. Expert opinion: Due to lack of familiarity with PH and its heterogeneous clinical expression, diagnosis is often delayed until advanced disease is present, a condition, requiring intensive hemodialysis and timely transplantation. Achieving the most beneficial outcome largely depends on the knowledge of the clinical spectrum, early diagnosis, and initiation of treatment before renal failure ensues. A number of preconditions required for substantial improvement in the care of orphan disease like PH have now been achieved or soon will come within reach, so new treatment options can be expected in the near future.Keywords
This publication has 101 references indexed in Scilit:
- Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type IMolecular Genetics and Metabolism, 2012
- Phenotypic Correction of a Mouse Model for Primary Hyperoxaluria With Adeno-associated Virus Gene TransferMolecular Therapy, 2011
- Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization withOxalobacterAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Modeling and therapy of human liver diseases using induced pluripotent stem cells: How far have we come?Hepatology, 2011
- Transplantation Outcomes in Primary HyperoxaluriaAmerican Journal of Transplantation, 2010
- Induced pluripotent stem cell–derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in miceJournal of Clinical Investigation, 2010
- Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cellsJournal of Clinical Investigation, 2010
- Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type IIIThe American Journal of Human Genetics, 2010
- Molecular Basis of Reduced Pyridoxine 5′-Phosphate Oxidase Catalytic Activity in Neonatal Epileptic Encephalopathy DisorderJournal of Biological Chemistry, 2009
- In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine:Glyoxylate AminotransferaseJournal of Biological Chemistry, 2008